Allergies News and Research

Latest Allergies News and Research

RXi Pharmaceuticals receives SBIR grant to further develop novel RNAi therapeutics

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced that it was awarded an Advanced Technology Small Business Innovation Research grant by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

13 Jul 2010

Line of moisture absorber products available to eliminate dampness that enables mold to grow

The stifling humidity accompanying this summer's extreme temperatures increases the chance that homeowners will experience significant indoor humidity and moisture that may lead to musty odors, allergens, and mold and mildew that lead to or aggravate allergies, asthma and other health concerns and can even lead to structural damage.

13 Jul 2010

UC Irvine public health professor to lead malaria field research in Southeast Asia

UC Irvine public health professor Guiyun Yan will lead groundbreaking malaria field research in impoverished reaches of China, Myanmar and Thailand, thanks to new federal funding. UCI will receive $4.7 million of a seven-year, $14.5 million award to Pennsylvania State University by the National Institute of Allergy & Infectious Diseases. Yan will collaborate with Penn State principal investigator Liwang Cui.

13 Jul 2010

NIAID names Case Western Reserve University as International Center of Excellence for Malaria Research

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) has named Case Western Reserve University School of Medicine as the lead institution of an International Center of Excellence for Malaria Research (ICEMR). The $7.9M seven-year grant will accelerate the control of malaria and help eliminate it worldwide.

13 Jul 2010

bitop's Ectoin allergy nasal spray reduces symptoms of acute allergic rhinitis in two-week crossover study

bitop AG, a biotech company specializing in the development of Ectoin®-containing medical devices, reports that Ectoin allergy nasal spray has been shown to significantly reduce symptoms of acute allergic rhinitis in a two-week observational, randomized, comparative crossover study with 50 patients suffering from acute allergic rhinitis. Based on this study, bitop performed a clinical trial on eyes drops and nasal spray in humans using an environmental exposure chamber (EEC) model.

12 Jul 2010

Discovery of antibodies that kill more than 90% of HIV viruses gives new hope for vaccine

"An effective vaccine against the AIDS virus may have moved one step closer to reality, researchers said Thursday," the Los Angeles Times reports. "Federal researchers have identified a pair of naturally occurring antibodies that are able to kill more than 90% of all strains of the AIDS virus, a finding they say could lead to the development of new treatments for HIV infections and to the production of the first successful vaccine against the virus" (Maugh, 7/9).

12 Jul 2010

Study examines impact of universal HIV testing, immediate ART program in Washington, DC

Implementing a program of universal HIV testing and immediate antiretroviral treatment for infected individuals could have a major impact on the HIV/AIDS epidemic in Washington, DC, but a new study finds that it would not halt the epidemic, something that a previous report had projected. In a paper that will appear in the August 15 issue of Clinical Infectious Diseases and has been released online, researchers find that the so-called "test-and-treat" strategy could reduce new HIV infections by 15 percent over the next five years while conferring large survival benefits to HIV-infected patients.

12 Jul 2010

Tulane University to receive $11.2M over seven years to establish international malaria research center

Tulane University will receive approximately $11.2 million over seven years from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, to establish an International Center of Excellence in Malaria Research for West and Central Africa. The money will be awarded in response to a multi-institutional proposal from Tulane University School of Public Health and Tropical Medicine.

9 Jul 2010

NIAID announces $14M in first-year funding to establish 10 new malaria research centers

In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.

9 Jul 2010

UC San Diego professor to establish new Peru/Brazil ICEMR to help control malaria

Tropical disease specialist Joseph Vinetz, MD, of the University of California, San Diego School of Medicine will lead an ambitious multi-national effort to help control and eventually conquer malaria, establishing a new Peruvian/Brazilian International Center of Excellence in Malaria Research Center with a seven-year, $9.2 million grant from the National Institutes of Health.

9 Jul 2010

Accudial's weight-based rotating labels prevent underdosing and overdosing in children's OTC medications

There is plenty to worry about when it comes to the job of parenting. However, wondering if a child is receiving the correct amount of over-the-counter (OTC) medication can now be a concern of the past, thanks to Children's AccuDial(R), a patented new line of children's medication available across Canada, with a dosing system based on body weight, not age.

9 Jul 2010

MSU-led research team to create new malaria prevention, control strategies in Malawi with $9.1M federal grant

As part of a continued effort to eliminate the scourge of malaria in the southern African nation of Malawi, a Michigan State University-led research team will use a $9.1 million federal grant to create new prevention and control strategies in the small, landlocked country.

9 Jul 2010

Media outlets examine efforts to tackle HIV/AIDS worldwide

Ahead of the International AIDS Conference, set for July 18-23 in Vienna, Austria, Reuters features an interview with Gottfried Hirnschall, the new director of the WHO's HIV Department, who speaks of the need for current funds for the global HIV/AIDS programs to be used more efficiently to achieve universal access to treatment for all HIV/AIDS patients.

9 Jul 2010

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it continues to make solid progress in its lyophilized recombinant Protective Antigen (rPA) anthrax vaccine development program. The Company has recently demonstrated that its lyophilized rPA vaccine candidate is structurally stable and potent at various temperatures up to and including 70 degrees centigrade.

9 Jul 2010

FDA-approved bioidentical estrogens help women manage common symptoms of menopause

Women looking for the best method to manage common symptoms of menopause, like hot flashes and night sweats, may not have access to credible information, especially when it comes to understanding their estrogen therapy options. In fact, there are an array of celebrities and authors who are simply not qualified to give medical advice about managing menopause, yet they dominate the internet and media space simply because of their popularity.

8 Jul 2010

Codex Alimentarius Commission provides new guidance to help improve food safety

The maximum amount of melamine allowed in powdered infant formula is 1 mg/kg and the amount of the chemical allowed in other foods and animal feed is 2.5 mg/kg, according to new rulings from the United Nations' food standards body, Codex Alimentarius Commission.

7 Jul 2010

FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy

DBV Technologies (DBV), a biotech company specializing in food allergy with innovative products for diagnosis and treatment, announced today the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application. DBV Technologies will begin clinical investigation of its lead food allergy desensitization candidate, VIASKIN® PEANUT, for the desensitization to peanut allergy. The Company expects to commence recruitment of peanut allergy patients at several medical centers in the U.S. this month.

7 Jul 2010

Caraco Pharmaceutical Laboratories commences shipping azelastine ophthalmic solution

Caraco Pharmaceutical Laboratories, Ltd. has started shipping azelastine ophthalmic solution, 0.05%. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA).

7 Jul 2010

Further analysis on Bcl11b gene and T-cell behaviouur from Caltech Biologists

When does a cell decide its particular identity? According to biologists at the California Institute of Technology (Caltech), in the case of T cells-immune system cells that help destroy invading pathogens-the answer is when the cells begin expressing a particular gene called Bcl11b.

3 Jul 2010

FDA issues consumer update on safety alerts

The Food and Drug Administration (FDA) has issued safety alerts about a number of products.

3 Jul 2010

Allergies News and Research

Latest Allergies News and Research

RXi Pharmaceuticals receives SBIR grant to further develop novel RNAi therapeutics

Line of moisture absorber products available to eliminate dampness that enables mold to grow

UC Irvine public health professor to lead malaria field research in Southeast Asia

NIAID names Case Western Reserve University as International Center of Excellence for Malaria Research

bitop's Ectoin allergy nasal spray reduces symptoms of acute allergic rhinitis in two-week crossover study

Discovery of antibodies that kill more than 90% of HIV viruses gives new hope for vaccine

Study examines impact of universal HIV testing, immediate ART program in Washington, DC

Tulane University to receive $11.2M over seven years to establish international malaria research center

NIAID announces $14M in first-year funding to establish 10 new malaria research centers

UC San Diego professor to establish new Peru/Brazil ICEMR to help control malaria

Accudial's weight-based rotating labels prevent underdosing and overdosing in children's OTC medications

MSU-led research team to create new malaria prevention, control strategies in Malawi with $9.1M federal grant

Media outlets examine efforts to tackle HIV/AIDS worldwide

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

FDA-approved bioidentical estrogens help women manage common symptoms of menopause

Codex Alimentarius Commission provides new guidance to help improve food safety

FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy

Caraco Pharmaceutical Laboratories commences shipping azelastine ophthalmic solution

Further analysis on Bcl11b gene and T-cell behaviouur from Caltech Biologists

FDA issues consumer update on safety alerts

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in